🧪AWS Launches Amazon Bio Discovery to Accelerate AI-Powered Life Sciences Research
AWS Launches Amazon Bio Discovery to Accelerate AI-Powered …
TL;DR
AWS announced Amazon Bio Discovery, a new AI-powered application that gives scientists direct access to biological foundation models trained on vast datasets.
AWS announced Amazon Bio Discovery, a new AI-powered application that gives scientists direct access to biological foundation models trained on vast datasets. With Memorial Sloan Kettering, the tool compressed antibody design for potential pediatric cancer therapies from months to weeks.
Key Points
New AWS application for scientists to design and test novel drugs
Provides direct access to biological foundation models
Cut antibody design time from months to weeks at Memorial Sloan Kettering
Further embeds AWS in pharma and biotech workflows
Why It Matters
AWS is making foundation-model-grade biology accessible to any pharma R&D team, potentially widening the pool of AI-native drug designers.
Frequently Asked Questions
Why does this matter?
AWS is making foundation-model-grade biology accessible to any pharma R&D team, potentially widening the pool of AI-native drug designers.
What happened?
AWS announced Amazon Bio Discovery, a new AI-powered application that gives scientists direct access to biological foundation models trained on vast datasets.
Comments
Be the first to comment
Enjoyed this article?
Get it daily. 7am. Free. Reads in 5 minutes.
Join 3,316 builders reading daily.